We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Biodegradable Nanoscaffolds Improve Chances for Stem Cell Therapies

By LabMedica International staff writers
Posted on 15 Nov 2018
Print article
Image: A biodegradable inorganic nanoscaffold consisting of stem cells, proteins, and drugs for advanced stem cell therapy and drug delivery (Photo courtesy of KiBum Lee, Letao Yang and Sy-Tsong Dean Chueng, Rutgers University).
Image: A biodegradable inorganic nanoscaffold consisting of stem cells, proteins, and drugs for advanced stem cell therapy and drug delivery (Photo courtesy of KiBum Lee, Letao Yang and Sy-Tsong Dean Chueng, Rutgers University).
The therapeutic potential of biodegradable nanoscaffolds made from manganese dioxide (MnO2) for advanced stem cell transplantation and neural tissue engineering was discussed favorably in a recent paper.

Stem cell transplantation, as a promising treatment for central nervous system diseases, has been hampered by crucial issues such as a low cell survival rate, incomplete differentiation, and limited neurite outgrowth in vivo. Inorganic and carbon-based nanoscaffolds designed to support and improve stem cell growth have been handicapped by their non-biodegradability and restricted biocompatibility, thereby delaying their wide clinical applications. On the contrary, MnO2 nanomaterials have proven to be biodegradable in other bio-applications such as cancer therapies, with MRI active Mn2+ ions as a degradation product.

Investigators at Rutgers University (New Brunswick, NJ, USA) designed nanoscaffolds that mimicked the natural tissue microenvironment to deliver physical and soluble cues. They took advantage of the biodegradability of MnO2 to incorporate its unique physiochemical properties into nano-sized structures for stem cell-based tissue engineering. The result, as described in the August 8, 2018, online edition of the journal Nature Communications was MnO2 nanomaterials-based three-dimensional hybrid nanoscaffolds that better regulated stem cell adhesion, differentiation into neurons, and neurite outgrowth in vitro and enabled enhanced stem cell transplantation benefits in vivo.

These biodegradable MnO2 nanoscaffolds could potentially serve as powerful tools for improving stem cell transplantation and advancing stem cell therapy.

"It has been a major challenge to develop a reliable therapeutic method for treating central nervous system diseases and injuries," said senior author Dr. KiBum Lee, professor of chemistry and chemical biology at Rutgers University. "Our enhanced stem cell transplantation approach is an innovative potential solution."

Related Links:
Rutgers University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.